The April 2026 federal rescheduling order was historic — but it was also incomplete. State-licensed medical cannabis moved to Schedule III, but recreational cannabis remained in Schedule I. The question of whether all marijuana gets rescheduled is now the subject of a formal DEA administrative hearing that began June 29, 2026. This is the proceeding that could determine the entire future trajectory of the legal cannabis industry in the United States.
What the Hearing Is Actually Deciding
The DEA’s June 29 hearing is focused on a single fundamental question: does the scientific and medical evidence support moving cannabis as a whole — not just FDA-approved products or state-licensed medical programs, but all marijuana — from Schedule I to Schedule III? The hearing follows years of review accelerated by a December 2025 executive order from President Trump directing the DOJ to complete the rescheduling process.
Why Schedule III for Rec Would Be Enormous
Right now, every recreational cannabis business in Michigan — and across the country — operates under Schedule I restrictions at the federal level. That means they can’t deduct normal business expenses on federal taxes, have severely limited banking access, and face unique legal exposure that no other legal retail industry deals with. Moving all cannabis to Schedule III would remove the most crippling of those restrictions. The Section 280E tax burden alone has cost the cannabis industry billions in effective over-taxation.
What Could Complicate the Process
The April 2026 order used a specific legal mechanism — the Attorney General’s authority to reschedule based on international treaty obligations — that some legal experts believe may face court challenges. If the rescheduling authority is contested, the broader process could get tangled in litigation even before the hearing produces a result.
What Stays the Same Even If It Passes
Important to note: federal rescheduling doesn’t federally legalize recreational cannabis. It doesn’t create a national retail framework. It doesn’t immediately change what you can bring across state lines or what employers can test for. What it does is remove federal criminal classification from a substance that Michigan and 23 other states have chosen to legalize for adult use. It’s a necessary step, not a finish line.
Michigan’s Stake in the Outcome
Michigan’s cannabis market recorded $3.18 billion in sales in 2025 and is one of the most active recreational markets in the country. A successful federal rescheduling would improve the financial health of every operator in the state and potentially stabilize the market contraction that’s been underway. We’ll be following the hearing closely. In the meantime, visit House of Dank — Michigan’s most trusted cannabis retailer with 15 locations statewide.
